Metabolic Syndrome in Patients with Lichen Planus: A Case-Control Study
Skin Health and Disease · 01.02.2024 · 4 (1)
DOI: 10.1002/ski2.315 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Skin Health and Disease, online erschienen am 30.11.2023. Verfasst von Mahesh Mathur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology College of Medical Sciences and Teaching Hospital Bharatpur Nepal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Abstract (Originalsprache)
Background
Lichen Planus (LP) is a chronic dermatosis affecting the skin and mucous membranes. Chronic inflammation and oxidative stress in patients with LP is a trigger predisposing to Metabolic Syndrome.
Objectives
To study the association of Metabolic Syndrome in patients with LP. Materials and Methods A hospital-based prospective case-control study was conducted from April 2021 to January 2023 including 75 histopathologically confirmed patients with LP and 82 age and sex-matched controls according to the inclusion and exclusion criteria. Metabolic Syndrome was diagnosed using Modified National Cholesterol Education Programme Adult Treatment Panel III criteria. Statistical analysis of the data was performed using Statistical Package for the Social Sciences software, version 26. The chi-square test was used for data analysis.
Results
The majority (30.6%) of the patients belonged to the age group 31–40 years. The mean age of patients with LP was 46.13 ± 14.9 years. Female predominance (69.3%) was observed in our study. Patients with classic LP (54.6%) were predominantly observed. Metabolic Syndrome was significantly prevalent in LP patients than in controls (32% vs. 13.4%, p = 0.005, OR 3.037) and was significantly associated with morphology (only oral mucosal involvement, 61.5%, p 0.027, OR 3.9), severity (severe LP, 58.6%, p < 0.001, OR 7.79), and duration of the disease (≥6 months, 55.5%, p 0.001, OR 5.42). 71% of Metabolic Syndrome was observed in females (p 0.847). Among patients with metabolic syndrome, the majority belonged to the age group between 31 and 40 years (37.5%, p 0.378). Systolic and Diastolic Blood Pressure values (≥130/85 mm of Hg), Serum Triglycerides (≥150 mg/dl), and Low-Density Lipoprotein (>130 mg/dl) were significantly elevated, and High-Density Lipoprotein (<40 mg/dl) was significantly low in LP than in controls (p < 0.05).
Conclusion
The study showed a significant association of Metabolic Syndrome in patients with LP. Thus, patients with LP need to be screened to avoid complications associated with Metabolic Syndrome that is, Diabetes Mellitus, Cardiovascular Disease, colorectal cancer, and stroke.
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology College of Medical Sciences and Teaching Hospital Bharatpur Nepal.
- Department of Community Medicine College of Medical Sciences and Teaching Hospital Bharatpur Nepal.
ORCID-Profile: Sunil Jaiswal, Supriya Paudel
Förderung
- This article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Zitieren
APA
Mathur, M., Thakur, N., Jaiswal, S., Das, G., Shah, S., Maharjan, S., Paudel, S., Shrestha, A., & Upadhyay, H. P. (2024). Metabolic Syndrome in Patients with Lichen Planus: A Case-Control Study. Skin Health and Disease, 4(1). https://doi.org/10.1002/ski2.315
Vancouver
Mathur M, Thakur N, Jaiswal S, Das G, Shah S, Maharjan S, et al. Metabolic Syndrome in Patients with Lichen Planus: A Case-Control Study. Skin Health and Disease. 2024;4(1). doi:10.1002/ski2.315
BibTeX
@article{Mathur2024,
author = {Mathur, Mahesh and Thakur, Neha and Jaiswal, Sunil and Das, Gautam and Shah, Swati and Maharjan, Srijana and Paudel, Supriya and Shrestha, Anjali and Upadhyay, Hari Prasad},
title = {Metabolic Syndrome in Patients with Lichen Planus: A Case-Control Study},
journal = {Skin Health and Disease},
year = {2024},
volume = {4},
number = {1},
doi = {10.1002/ski2.315}
}
EUVIMED